Skip to content

Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures

An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00160290
Enrollment
97
Registered
2005-09-12
Start date
2002-03-31
Completion date
2006-06-30
Last updated
2008-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fissures, Hemorrhoids

Keywords

lactulose, randomised clinical trial, hemorrhoids, anal fissures

Brief summary

To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoids or anal fissure. To compare efficacy and quality of life in patients treated either with lactulose or plantago ovate.

Interventions

DRUGLactulose

15 mL / 12 hours

DRUGPlantago ovata

3,5 g / 12 hours

Sponsors

Solvay Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.

Exclusion criteria

* Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.

Design outcomes

Primary

MeasureTime frame
Quality of life of patients with hard stools and hemorrhoids or anal fissure6 weeks

Secondary

MeasureTime frame
Gastrointestinal Symptoms Rating Scale6 weeks
Bristol stool consistency scale6 weeks
Number of episodes of rectal bleeding6 weeks
Need of rescue medication6 weeks

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026